Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus (Diabetes Metab J 2022;46:93-103).
作者信息
Kim Gyuri
机构信息
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
出版信息
Diabetes Metab J. 2022 May;46(3):512-514. doi: 10.4093/dmj.2022.0134. Epub 2022 May 25.
Abstract
摘要
相似文献
1
Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus (Diabetes Metab J 2022;46:93-103).中国1型糖尿病成年患者代谢综合征与微血管并发症之间的关联（《糖尿病与代谢杂志》2022年；46:93 - 103）
Diabetes Metab J. 2022 May;46(3):512-514. doi: 10.4093/dmj.2022.0134. Epub 2022 May 25.
2
Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus (Diabetes Metab J 2022;46:93-103).中国1型糖尿病成年患者的代谢综合征与微血管并发症之间的关联（《糖尿病与代谢杂志》2022年；46:93 - 103）
Diabetes Metab J. 2022 May;46(3):515-516. doi: 10.4093/dmj.2022.0149. Epub 2022 May 25.
3
Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus.代谢综合征与中国 1 型糖尿病成人微血管并发症的关系。
Diabetes Metab J. 2022 Jan;46(1):93-103. doi: 10.4093/dmj.2020.0240. Epub 2021 Aug 31.
4
Metabolic syndrome in type 1 diabetes and its association with diabetes complications.1 型糖尿病中的代谢综合征及其与糖尿病并发症的关系。
Diabet Med. 2021 Feb;38(2):e14376. doi: 10.1111/dme.14376. Epub 2020 Sep 21.
5
Liver enzymes, type 2 diabetes, and metabolic syndrome in middle-aged, urban Chinese men.中年城市汉族男性的肝酶、2 型糖尿病和代谢综合征。
Metab Syndr Relat Disord. 2011 Aug;9(4):305-11. doi: 10.1089/met.2011.0016. Epub 2011 Apr 15.
6
Impact of excluding hyperglycemia from international diabetes federation metabolic syndrome diagnostic criteria on prevalence of the syndrome and its association with microvascular complications, in adult patients with type 1 diabetes.将高血糖排除在国际糖尿病联盟代谢综合征诊断标准之外对 1 型糖尿病成年患者综合征的患病率及其与微血管并发症的关系的影响。
Endocrine. 2022 Jun;76(3):601-611. doi: 10.1007/s12020-022-03041-8. Epub 2022 Mar 28.
7
Geographic variation in the frequency of abdominal adiposity and metabolic syndrome in Italian adolescents with type 1 diabetes.
Acta Diabetol. 2014 Feb;51(1):163-5. doi: 10.1007/s00592-013-0494-6. Epub 2013 Jun 27.
8
Current challenges of diabetes and metabolic disorders in China.中国糖尿病与代谢紊乱的当前挑战。
Diabetes Obes Metab. 2023 Apr;25 Suppl 1:3-4. doi: 10.1111/dom.15048. Epub 2023 Mar 28.
9
Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China.中国上海20岁以上城市居民肥胖及其合并症的流行病学研究。
Obes Rev. 2002 Aug;3(3):157-65. doi: 10.1046/j.1467-789x.2002.00071.x.
10
Prevalence and comorbidities of double diabetes.双糖尿病的患病率和共病情况。
Diabetes Res Clin Pract. 2016 Sep;119:48-56. doi: 10.1016/j.diabres.2016.06.003. Epub 2016 Jun 25.
本文引用的文献
1
Effects of SGLT2 Inhibitors on Renal Outcomes in Patients With Chronic Kidney Disease: A Meta-Analysis.钠-葡萄糖协同转运蛋白2抑制剂对慢性肾脏病患者肾脏结局的影响：一项荟萃分析
Front Med (Lausanne). 2021 Nov 1;8:728089. doi: 10.3389/fmed.2021.728089. eCollection 2021.
2
Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus.代谢综合征与中国 1 型糖尿病成人微血管并发症的关系。
Diabetes Metab J. 2022 Jan;46(1):93-103. doi: 10.4093/dmj.2020.0240. Epub 2021 Aug 31.
3
Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes.二甲双胍改善 1 型糖尿病青少年的外周胰岛素敏感性。
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3265-3278. doi: 10.1210/jc.2019-00129.
4
Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes.1型糖尿病青少年血脂异常的患病率及其与微量白蛋白尿发生的关系。
Diabetes Care. 2009 Apr;32(4):658-63. doi: 10.2337/dc08-1641. Epub 2009 Jan 26.
5
Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study.1型糖尿病青少年与非1型糖尿病青少年的血脂和脂蛋白谱：青少年糖尿病研究（SEARCH）病例对照研究
Diabetes Care. 2009 Mar;32(3):416-20. doi: 10.2337/dc08-1775. Epub 2008 Dec 17.
6
Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.1型糖尿病中的胰岛素抵抗、代谢综合征及并发症风险：糖尿病控制与并发症试验中的“双重糖尿病”
Diabetes Care. 2007 Mar;30(3):707-12. doi: 10.2337/dc06-1982.
7
The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey.代谢综合征是糖尿病微血管和大血管并发症的风险指标：基于多中心糖尿病诊所调查的Metascreen研究结果
Diabetes Care. 2006 Dec;29(12):2701-7. doi: 10.2337/dc06-0942.
8
The metabolic syndrome.代谢综合征
Lancet. 2005;365(9468):1415-28. doi: 10.1016/S0140-6736(05)66378-7.
9
Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial.糖尿病控制与并发症试验中强化糖尿病治疗对1型糖尿病成年患者体重及身体成分的影响。
Diabetes Care. 2001 Oct;24(10):1711-21. doi: 10.2337/diacare.24.10.1711.
10
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.血管紧张素转换酶抑制剂与非糖尿病肾病的进展。患者水平数据的荟萃分析。
Ann Intern Med. 2001 Jul 17;135(2):73-87. doi: 10.7326/0003-4819-135-2-200107170-00007.
Zotero 插件